Shopping Cart
- Remove All
- Your shopping cart is currently empty
AS1269574 (AS 1269574) is a potent, orally available GPR119 agonist with potential for type 2 diabetes research.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
2 mg | $33 | In Stock | |
5 mg | $52 | In Stock | |
10 mg | $88 | In Stock | |
25 mg | $177 | In Stock | |
50 mg | $285 | In Stock | |
100 mg | $428 | In Stock | |
200 mg | $623 | In Stock | |
1 mL x 10 mM (in DMSO) | $60 | In Stock |
Description | AS1269574 (AS 1269574) is a potent, orally available GPR119 agonist with potential for type 2 diabetes research. |
In vitro | AS1269574 had an EC(50) value of 2.5μM in HEK293 cells transiently expressing human GPR119 and enhanced insulin secretion in the mouse pancreatic β-cell line MIN-6 only under high-glucose (16.8mM) conditions.?This contrasted with the action of the sulfonylurea glibenclamide, which also induced insulin secretion under low-glucose conditions (2.8mM)[1]. |
In vivo | In in vivo studies, a single administration of AS1269574 to normal mice reduced blood glucose levels after oral glucose loading based on the observed insulin secretion profiles.?Significantly, AS1269574 did not affect fed and fasting plasma glucose levels in normal mice.?AS1269574 represents a novel structural class of small molecule, orally administrable GPR119 agonists with GSIS and promising potential for the treatment of type 2 diabetes[1]. |
Alias | AS 1269574 |
Molecular Weight | 308.17 |
Formula | C13H14BrN3O |
Cas No. | 330981-72-1 |
Smiles | Cc1cc(NCCO)nc(n1)-c1ccc(Br)cc1 |
Relative Density. | no data available |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 250 mg/mL (811.24 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.